Daniel Rybak is a Ph.D. student at the Institute of Fundamental Technological Research of Polish Academy of Sciences in Warsaw (IPPT PAN). His master thesis has been focused on biodegradable PLACL co-polymer nanoparticles with paclitaxel as a drug delivery system in cancer treatment. His area of research interests includes drugs, drug release, and novel drug delivery systems. His activities also include basic and preclinical researches on new formulations.